Rite Aid Corp (RAD.N)
2.79USD
17 May 2013
$0.19 (+7.31%)
$2.60
$2.61
$2.80
$2.60
6,111,264
2,465,621
$2.80
$0.95
RAD.N
About
Overall
| Beta: | 2.50 |
| Market Cap (Mil.): | $2,523.74 |
| Shares Outstanding (Mil.): | 904.56 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| RAD.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 24.63 | 19.37 | 41.15 |
| EPS (TTM): | 0.11 | -- | -- |
| ROI: | 2.54 | 9.84 | 80.39 |
| ROE: | -- | 11.07 | 88.65 |
Fitch Affirms Rite Aid's IDR at 'B-'; Outlook Stable
(The following statement was released by the rating agency) NEW YORK, April 26 (Fitch) Fitch Ratings has affirmed its ratings on Rite Aid Corporation (Rite Aid), including its Issuer Default Rating (IDR) at 'B-'. The Rating Outlook is Stable. A complete list of ratings is provided at the end of this release. KEY RATING DRIVERS: --Rite Aid's high leverage and operating statistics that significantly trail its two major competitors; --Strong market share position as the third largest U.S. drug
Canada's Jean Coutu cuts stake in Rite Aid to 11.7 pct
April 16 - Canadian drugstore chain Jean Coutu Group Inc said it has sold 72.5 million shares in Rite Aid Corp, bringing its stake in the company to 11.7 percent.
BRIEF-Rite Aid shares up 4.3 pct in premarket trading
NEW YORK, April 12 - Rite Aid Corp : * Shares up 4.3 percent in premarket trading
Rite Aid posts quarterly and annual profits, shares up
- Rite Aid Corp posted its second consecutive quarterly profit on Thursday, topping Wall Street's expectations, as the third-largest U.S. drugstore chain filled more prescriptions and sold more generic drugs, which carry higher profit margins.
UPDATE 3-Rite Aid posts quarterly and annual profits, shares up
* Shares up 20 percent to $2.14; highest level since 2009
BRIEF-Rite Aid sees spending about $65 million on prescription file purchases this year
CHICAGO, April 11 - Rite Aid Corp : * Sees spending about $65 million on prescription file purchases this year * Says would do more than $65 million in file buys if possible
BRIEF-Rite Aid shares up 10.6 pct in premarket trading
NEW YORK, April 11 - Rite Aid Corp : * Shares up 10.6 percent in premarket trading after results
Rite Aid posts second quarterly profit in a row
April 11 - Rite Aid Corp posted its second consecutive quarterly profit on Thursday, as the third largest U.S. drugstore chain filled more prescriptions and sold more generic drugs, which carry higher profit margins.
TEXT - Fitch rates Rite Aid's new revolver and secured term loans
Feb 5 - Fitch Ratings has assigned a rating of 'BB-/RR1' to Rite Aid Corporation's (Rite Aid) proposed new $1.725 billion secured revolving credit facility due 2018, $900 million senior secured term loan B due 2020, and $470 senior secured second lien term loan due 2020. The Rating Outlook is Stable. The proceeds will be used to refinance Rite Aid's existing $1.175 billion ABL facility due 2015, $1.039 billion first lien secured term loan due 2014, $410 million first lien secured notes due
Rite Aid returns to profit, raises forecast
- Rite Aid Corp reported its first quarterly profit in more than five years on Thursday, helped by growth in the number of prescriptions filled and higher comparable sales of general merchandise at its stores.
Competitors
| Price | Change | |
|---|---|---|
| Wal-Mart Stores, Inc. (WMT.N) | $77.87 | -0.63 |
| CVS Caremark Corporation (CVS.N) | $59.44 | +0.07 |
| AmerisourceBergen Corp. (ABC.N) | $54.99 | +0.59 |
| Walgreen Company (WAG.N) | $49.61 | +0.77 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Wright Reports
|
$472.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
